Skip to main content
. 2013 Feb 6;8(2):e55905. doi: 10.1371/journal.pone.0055905

Figure 2. mRNA levels of 5α-Reductase type 1 (5α-R1) (panel A), 5α-Reductase type 2 (5α-R2) (panel B), 5α-Reductase type 3 (5α-R3) (panel C) and aromatase (panel D) in prostate of control and BPA-treated rats at doses of 25, 50, 300, or 600 µg/Kg/d for 4 days.

Figure 2

P<0.01 vs. Control animals.